New Collaboration Seeks to Speed Huntington’s Disease Drug Licensing This article originally appeared on HDBuzz and is reprinted here under Creative Commons license. Critical Path Institute launches
C-Path and CHDI launch consortium to accelerate development of Huntington’s disease therapies Tucson, AZ, and New York, NY – March 28, 2018 – The Critical Path Institute (C-Path), together with CHDI Foun
C-Path, CHDI Foundation, and CDISC Announce Public Review Period for Huntington’s Disease Therapeutic Area User Guide September 11, 2017 TUCSON, AZ, NEW YORK, NY, and AUSTIN, TX – September 11, 2017 – Critical Path Institute (C-Pa
Critical Path Institute and CHDI Foundation, Inc., establish a consortium to expedite approval of Huntington’s disease therapeutics Oct 31, 2016 Critical Path Institute and CHDI Foundation, Inc., establish a consortium to expedite approval of Hunti
